1-(3-chlorophenyl)piperazine has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkóczy, J; Bilkei-Gorzó, A; Gacsályi, I; Hársing, LG; Hegedus, E; Kapus, GL; Kompagne, H; Lévay, G; Leveleki, C; Vegh, M | 1 |
| Arai, Y; Kaiho, Y; Kawamorita, N; Miyazato, M; Yoshimura, N | 1 |
2 other study(ies) available for 1-(3-chlorophenyl)piperazine and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
| Article | Year |
|---|---|
Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Conflict, Psychological; Data Interpretation, Statistical; Diazepam; Electrophysiology; Excitatory Amino Acid Antagonists; Hippocampus; Male; Membrane Potentials; Mice; Motor Activity; Neurons; Patch-Clamp Techniques; Piperazines; Quinoxalines; Radioligand Assay; Rats; Rats, Wistar; Receptors, AMPA; Telencephalon | 2008 |
Roles of the spinal glutamatergic pathway activated through α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors and its interactions with spinal noradrenergic and serotonergic pathways in the rat urethral continence mechanisms.
Topics: Animals; Excitatory Amino Acid Antagonists; Female; Fluoxetine; Norepinephrine; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, AMPA; Reflex; Serotonin Receptor Agonists; Sneezing; Urethra; Urinary Incontinence, Stress | 2015 |